86 related articles for article (PubMed ID: 26236582)
1. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.
Valdez RH; Tonin LT; Ueda-Nakamura T; Silva SO; Dias Filho BP; Kaneshima EN; Yamada-Ogatta SF; Yamauchi LM; Sarragiotto MH; Nakamura CV
Antimicrob Agents Chemother; 2012 Jan; 56(1):507-12. PubMed ID: 22037851
[TBL] [Abstract][Full Text] [Related]
4. Identification of host antioxidant effectors as thioridazine targets: Impact on cardiomyocytes infection and Trypanosoma cruzi-induced acute myocarditis.
Liz Belli Cassa Domingues E; Gonçalves-Santos E; Santana Caldas I; Vilela Gonçalves R; Caetano-da-Silva JE; Cardoso Santos E; Mól Pelinsari S; Figueiredo Diniz L; Dias Novaes R
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167264. PubMed ID: 38806073
[TBL] [Abstract][Full Text] [Related]
5. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of novel
Espinoza-Chávez RM; Oliveira Rezende Júnior C; de Souza ML; Pauli I; Valli M; Gomes Ferreira LL; Chelucci RC; Michelan-Duarte S; Krogh R; Romualdo da Silva FB; Cruz FC; de Oliveira AS; Andricopulo AD; Dias LC
Future Med Chem; 2024 Feb; 16(3):253-269. PubMed ID: 38193294
[No Abstract] [Full Text] [Related]
7. In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi.
Ramírez-Macías I; Marín C; Chahboun R; Messouri I; Olmo F; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
Am J Trop Med Hyg; 2012 Sep; 87(3):481-8. PubMed ID: 22802442
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
de Araújo JS; França da Silva C; Batista DDGJ; Nefertiti A; Fiuza LFA; Fonseca-Berzal CR; Bernardino da Silva P; Batista MM; Sijm M; Kalejaiye TD; de Koning HP; Maes L; Sterk GJ; Leurs R; Soeiro MNC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601163
[TBL] [Abstract][Full Text] [Related]
9. Anti-trypanosomal Lignans Isolated from Salvadoran
Castillo UG; Uekusa Y; Nishimura T; Kiuchi F; Martínez ML; Menjívar J; Nakajima-Shimada J; Núñez MJ; Kikuchi H
J Nat Prod; 2024 Apr; 87(4):1067-1074. PubMed ID: 38631020
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression and Chagas disease: a management challenge.
Pinazo MJ; Espinosa G; Cortes-Lletget C; Posada Ede J; Aldasoro E; Oliveira I; Muñoz J; Gállego M; Gascon J
PLoS Negl Trop Dis; 2013; 7(1):e1965. PubMed ID: 23349998
[TBL] [Abstract][Full Text] [Related]
11. Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy.
Khan AA; Langston HC; Walsh L; Roscoe R; Jayawardhana S; Francisco AF; Taylor MC; McCann CJ; Kelly JM; Lewis MD
Nat Commun; 2024 May; 15(1):4400. PubMed ID: 38782898
[TBL] [Abstract][Full Text] [Related]
12. Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.
Branquinho RT; Mosqueira VC; de Oliveira-Silva JC; Simões-Silva MR; Saúde-Guimarães DA; de Lana M
Antimicrob Agents Chemother; 2014; 58(4):2067-75. PubMed ID: 24449777
[TBL] [Abstract][Full Text] [Related]
13. Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease.
Liu Z; Ulrich vonBargen R; Kendricks AL; Wheeler K; Leão AC; Sankaranarayanan K; Dean DA; Kane SS; Hossain E; Pollet J; Bottazzi ME; Hotez PJ; Jones KM; McCall LI
Nat Commun; 2023 Oct; 14(1):6769. PubMed ID: 37880260
[TBL] [Abstract][Full Text] [Related]
14. Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.
Davies C; Marino Cardozo R; Sánchez Negrette O; Mora MC; Chung MC; Basombrío MA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3584-9. PubMed ID: 20566772
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and in Vivo Study of a Photostable Quinone Compound with Enhanced Therapeutic Efficacy against Chagas Disease.
Suto Y; Inoue N; Tagod MSO; Onizuka Y; Nobuta T; Ishii M; Inaoka DK; Kanamitsu K; Yamagiwa N; Nakajima-Shimada J
Chem Pharm Bull (Tokyo); 2024; 72(4):389-392. PubMed ID: 38644164
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles.
Carneiro ZA; Maia PI; Sesti-Costa R; Lopes CD; Pereira TA; Milanezi CM; da Silva MA; Lopez RF; Silva JS; Deflon VM
PLoS Negl Trop Dis; 2014 May; 8(5):e2847. PubMed ID: 24810753
[TBL] [Abstract][Full Text] [Related]
17. A novel palladium complex with a coumarin-thiosemicarbazone hybrid ligand inhibits Trypanosoma cruzi release from host cells and lowers the parasitemia in vivo.
Rostán S; Porto S; Barbosa CLN; Assis D; Alvarez N; Machado FS; Mahler G; Otero L
J Biol Inorg Chem; 2023 Dec; 28(8):711-723. PubMed ID: 37768364
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin degradation as biomarker for
Hernández-Cuevas NA; Marín-Cervera A; Garcia-Polanco S; Martínez-Vega P; Rosado-Vallado M; Dumonteil E
Parasitology; 2021 Aug; 148(9):1067-1073. PubMed ID: 34024298
[TBL] [Abstract][Full Text] [Related]
19. CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.
Buccheri R; Kassab MJ; Freitas VL; Silva SC; Bezerra RC; Khoury Z; Shikanai-Yasuda MA; Vidal JE
Rev Inst Med Trop Sao Paulo; 2015 Dec; 57(6):531-5. PubMed ID: 27049711
[TBL] [Abstract][Full Text] [Related]
20. Immune Evasion Strategies of Trypanosoma cruzi.
Flávia Nardy A; Freire-de-Lima CG; Morrot A
J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
